Literature DB >> 32900565

NK cells in the tumor microenvironment: Prognostic and theranostic impact. Recent advances and trends.

Jules Russick1, Carine Torset1, Edouard Hemery1, Isabelle Cremer2.   

Abstract

NK cells orchestrate the tumor destruction and control metastasis in a coordinated way with other immune cells of the tumor microenvironment. However, NK cell infiltration in the tumor microenvironment is limited, and tumor cells have developed numerous mechanisms to escape NK cell attack. As a result, NK cells that have been able to infiltrate the tumors are exhausted, and metabolically and functionally impaired. Depending this impairment the prognostic and theranostic values of NK cells differ depending on the studies, the type of cancer, the stage of tumor and the nature of the tumor microenvironment. Extensive studies have been done to investigate different strategies to improve the NK cell function, and nowadays, a battery of therapeutic tools are being tested, with promising results.
Copyright © 2020 Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  NK cells; Prognostic; Theranostic; Tumor microenvironment

Year:  2020        PMID: 32900565     DOI: 10.1016/j.smim.2020.101407

Source DB:  PubMed          Journal:  Semin Immunol        ISSN: 1044-5323            Impact factor:   11.130


  10 in total

1.  Role of NK Cells in Tumor Progression.

Authors:  Iñigo Terrén; Francisco Borrego
Journal:  Exp Suppl       Date:  2022

2.  Single-cell multiomics reveals increased plasticity, resistant populations, and stem-cell-like blasts in KMT2A-rearranged leukemia.

Authors:  Changya Chen; Wenbao Yu; Fatemeh Alikarami; Qi Qiu; Chia-Hui Chen; Jennifer Flournoy; Peng Gao; Yasin Uzun; Li Fang; James W Davenport; Yuxuan Hu; Qin Zhu; Kai Wang; Clara Libbrecht; Alex Felmeister; Isaiah Rozich; Yang-Yang Ding; Stephen P Hunger; Carolyn A Felix; Hao Wu; Patrick A Brown; Erin M Guest; David M Barrett; Kathrin M Bernt; Kai Tan
Journal:  Blood       Date:  2022-04-07       Impact factor: 22.113

3.  Increased Expression of Mitochondrial UQCRC1 in Pancreatic Cancer Impairs Antitumor Immunity of Natural Killer Cells via Elevating Extracellular ATP.

Authors:  Hui Cong; Jian Gao; Qing Wang; Min Du; Huimin Li; Qian Li; Jin Li; Yiyi Liang; Dan Zhao; Hancao Yang; Yu Gan; Hong Tu
Journal:  Front Oncol       Date:  2022-06-13       Impact factor: 5.738

Review 4.  Natural killer cell homing and trafficking in tissues and tumors: from biology to application.

Authors:  Guang He Ran; Yu Qing Lin; Lei Tian; Tao Zhang; Dong Mei Yan; Jian Hua Yu; You Cai Deng
Journal:  Signal Transduct Target Ther       Date:  2022-06-29

Review 5.  Targeting myeloid-derived suppressor cells to enhance natural killer cell-based immunotherapy.

Authors:  Shweta Joshi; Andrew Sharabi
Journal:  Pharmacol Ther       Date:  2022-02-02       Impact factor: 13.400

6.  Irradiated Tumor Fibroblasts Avoid Immune Recognition and Retain Immunosuppressive Functions Over Natural Killer Cells.

Authors:  Nannan Yang; Kristin Lode; Rodrigo Berzaghi; Ashraful Islam; Inigo Martinez-Zubiaurre; Turid Hellevik
Journal:  Front Immunol       Date:  2021-01-22       Impact factor: 7.561

7.  TIM-3 levels correlate with enhanced NK cell cytotoxicity and improved clinical outcome in AML patients.

Authors:  Jana Rakova; Iva Truxova; Peter Holicek; Cyril Salek; Michal Hensler; Lenka Kasikova; Josef Pasulka; Monika Holubova; Marek Kovar; Daniel Lysak; Justin P Kline; Zdenek Racil; Lorenzo Galluzzi; Radek Spisek; Jitka Fucikova
Journal:  Oncoimmunology       Date:  2021-03-08       Impact factor: 8.110

Review 8.  Leveraging NKG2D Ligands in Immuno-Oncology.

Authors:  Mercedes Beatriz Fuertes; Carolina Inés Domaica; Norberto Walter Zwirner
Journal:  Front Immunol       Date:  2021-07-29       Impact factor: 7.561

Review 9.  The yin-yang effects of immunity: From monoclonal gammopathy of undetermined significance to multiple myeloma.

Authors:  Zhigang Yi; Tao Ma; Jia Liu; Wenting Tie; Yanhong Li; Jun Bai; Lijuan Li; Liansheng Zhang
Journal:  Front Immunol       Date:  2022-07-25       Impact factor: 8.786

Review 10.  The Natural Killer-Dendritic Cell Immune Axis in Anti-Cancer Immunity and Immunotherapy.

Authors:  Erin E Peterson; Kevin C Barry
Journal:  Front Immunol       Date:  2021-02-03       Impact factor: 7.561

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.